Otros idiomas KPC Pharmaceuticals,Inc

Acciones

600422

CNE0000015P8

Precio de cierre Shanghai S.E. Otros sitios de cotización 00:00:00 30/04/2024			Varia. Cinco días.	Varia. 1 de enero.
22,72 ^CNY	-0,66 %		+8,76 %	+8,92 %

19/04	KPC Pharmaceuticals,Inc informa de los resultados de beneficios del primer trimestre finalizado el 31 de marzo de 2024	CI
21/03	KPC Pharmaceuticals,Inc informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

KPC Pharmaceuticals,Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04
Kunyao Group Receives Clinical Trial Approval for FMF Drug	17/04
KPC Pharmaceuticals,Inc Proposes Cash Dividend	21/03
KPC Pharmaceuticals,Inc Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
KPC Pharmaceuticals,Inc Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
KPC Pharmaceuticals’ Antimalarial Drug Passes WHO Prequalification	13/10/23
KPC Pharmaceuticals' Attributable Profit Rises 3.1%; Shares Slip 4%	30/08/23
KPC Pharmaceuticals,Inc Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
KPC Pharmaceuticals' Q1 Net Profit Jumps; Shares Rise 7%	28/04/23
KPC Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
KPC Pharma’s Shingles Drug Added to China’s Medical Insurance Catalog	20/01/23
KPC Pharma to Hold Phase II Clinical Trial of Stroke Drug	20/01/23
China Resources Pharmaceutical Completes Transfer of KPC Pharmaceutical Shares to Unit	03/01/23
KPC Pharmaceuticals CFO Steps Down	02/01/23
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. completed the acquisition of a 28% stake in KPC Pharmaceuticals, Inc. from Hofon Pharmaceuticals Co.,Ltd. and Holley Group Company Limited.	30/12/22
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	24/10/22
KPC Pharmaceuticals Unit Receives Marketing Authorization of Angong Niuhuang Pills; Shares Jump 7%	21/10/22
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	15/08/22
Chinese Shares Rebound; KPC Pharma Rallies 10% on CR Sanjiu’s $431 Million Stake Purchase	10/05/22
CR Sanjiu Medical & Pharma to Buy 28% Stake in KPC Pharma For $430 Million	10/05/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas KPC Pharmaceuticals,Inc

Acciones

600422

CNE0000015P8

Otros idiomas

Filtros